SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-008658
Filing Date
2023-12-06
Accepted
2023-12-06 16:01:08
Documents
13
Period of Report
2023-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K canna_8k.htm   iXBRL 8-K 37958
2 AMENDED AND RESTATED MEMBERSHIP INTEREST PURCHASE AGREEMENT canna_ex0201.htm EX-2.1 213206
  Complete submission text file 0001683168-23-008658.txt   468960

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cpmd-20231122.xsd EX-101.SCH 3030
4 XBRL LABEL FILE cpmd-20231122_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cpmd-20231122_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 3414
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 231469567
SIC: 2834 Pharmaceutical Preparations